Emerging Markets Regulatory Tracker: Australia (Vol. 4 No. 54)
This article was originally published in PharmAsia News
Executive Summary
Australia’s Therapeutic Goods Administration issues guidance on registration of new prescription medicine, or existing products, that involve clinical, non-clinical or bioequivalence data.